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Abstract
Exosomes are membranous nanovesicles released by most cell types from multi-vesicular endosomes. They are speculated
to transfer molecules to neighboring or distant cells and modulate many physiological and pathological procedures.
Exosomes released from the gastrointestinal epithelium to the basolateral side have been implicated in antigen
presentation. Here, we report that luminal release of exosomes from the biliary and intestinal epithelium is increased
following infection by the protozoan parasite Cryptosporidium parvum. Release of exosomes involves activation of TLR4/
IKK2 signaling through promoting the SNAP23-associated vesicular exocytotic process. Downregulation of let-7 family
miRNAs by activation of TLR4 signaling increases SNAP23 expression, coordinating exosome release in response to C.
parvum infection. Intriguingly, exosomes carry antimicrobial peptides of epithelial cell origin, including cathelicidin-37 and
beta-defensin 2. Activation of TLR4 signaling enhances exosomal shuttle of epithelial antimicrobial peptides. Exposure of C.
parvum sporozoites to released exosomes decreases their viability and infectivity both in vitro and ex vivo. Direct binding to
the C. parvum sporozoite surface is required for the anti-C. parvum activity of released exosomes. Biliary epithelial cells also
increase exosomal release and display exosome-associated anti-C. parvum activity following LPS stimulation. Our data
indicate that TLR4 signaling regulates luminal exosome release and shuttling of antimicrobial peptides from the
gastrointestinal epithelium, revealing a new arm of mucosal immunity relevant to antimicrobial defense.
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Introduction
Eukaryotic cells release membrane vesicles into their extracel-
lular environment under physiological and pathological conditions
[1]. These vesicles mediate the secretion of a wide variety of
proteins, lipids, mRNAs, and microRNAs (miRNAs), interact with
neighboring cells, and thereby traffic molecules from the
cytoplasm and membranes of one cell to other cells or extracellular
spaces [1,2]. There is increasing evidence that secreted vesicles
play an important role in normal physiological processes,
development, and viral infection and other human disease [3–6].
Exosomes represent a specific subtype of secreted membrane
vesicles that are around 30–100 nm in size, formed inside the
secreting cells in endosomal compartments called multi-vesicular
bodies (MVBs) [2]. Exosomes are produced by a variety of cells
(e.g., reticulocytes, epithelial cells, neurons, tumor cells) and have
been found in bronchoalveolar lavage, urine, serum, bile, and
breast milk [2,7,8]. The composition of exosomes is heterogenic,
depending on the cellular origin of the exosome. Exosomes do not
contain a random array of intracellular proteins, but a specific set
of protein families arising from the plasma membrane, the
endocytic pathway, and the cytosol, especially those of endosomal
origin, such as CD63, ICAM-1, and MHC molecules [2,9–13].
Secretion of exosomes is regulated by various stimuli, including
the activation of P2X receptor by ATP on monocytes and
neutrophils, thrombin receptor on platelets, and Toll-like receptor
(TLR) 4 by LPS on dendritic cells [2,14,15]. Formation of
intraluminal vesicles of MVBs and targeting of transmembrane
proteins to these vesicles involve a complex intracellular sorting
network, including the endosomal sorting complex required for
transport (ESCRT) machinery [2,15]. Fusion of MVBs with
plasma membrane is an exocytotic process that requires the
association of v-SNAREs (from the vesicles) and t-SNAREs (at the
membrane) to form a ternary SNARE (SNAP receptor) complex.
The SNARE complex brings the two membranes in apposition, a
necessary step in overcoming the energy barrier required for
membrane fusion [16]. Several Rab family proteins, including
Rab11 and Rab27b, are key regulators of the exosome secretion
pathway and are involved in MVB docking at the plasma
membrane [17].
Epithelial cells along the mucosal surface provide the front
line of defense against luminal pathogen infection in the
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gastrointestinal tract and are an important component of
gastrointestinal mucosal immunity [18,19]. TLRs recognize
discrete pathogen-associated molecular patterns and activate a
set of adaptor proteins (e.g., MyD88) and intracellular kinases (e.g.,
IKKs), leading to the nuclear translocation of transcription factors,
such as NF-kB [20]. Activation of the TLR/NF-kB pathway
initiates a series of host defense reactions against pathogens,
including parasites. Exosomes derived from the apical and
basolateral sides of gastrointestinal epithelial cells, including biliary
epithelial cells, have recently been identified, but their physiologic
and pathologic relevance is still unclear [21,22]. These basolateral
exosomes have been shown to modulate lymphocyte immune
responses during mucosal infection [21]. Intestinal epithelial cell-
derived exosomes containing avb6 integrin and food antigen
induced the generation of tolerogenic dendritic cells in a model of
tolerance induction [23]. The presence of these intestinal epithelial
cell-derived exosomes impacted the development of antigen-
specific T regulatory cells [23]. Release of exosomes into the bile
has been shown to influence intracellular regulatory mechanisms
and modulate biliary epithelial cell proliferation via interactions
with epithelial primary cilia [24].
Cryptosporidium parvum is an obligate intracellular protozoan of
the phylum Apicomplexa that infects intestinal and biliary
epithelial cells [25]. Infection activates TLR4 signaling in host
epithelial cells through direct parasite-host cell interactions
[19,25]. Due to the ‘‘minimally invasive’’ nature of infection,
epithelial cells play a key role in activating and communicating
with the host immune system against C. parvum infection.
MicroRNAs are small regulatory RNAs that mediate either
mRNA cleavage or translational suppression, resulting in gene
suppression [26]. miRNAs can be seen as a fine-tuning for the
cellular responses to external influences, and might be important
players in the regulation of host immune response. In our previous
studies, we demonstrated that activation of TLR4/NF-kB
signaling in epithelial cells regulates transcription of miRNA genes
to orchestrate host anti-C. parvum immune responses through
modulation of miRNA-mediated posttranscriptional suppression
[27,28]. In the work described here, we found that C. parvum
infection stimulates host epithelial monolayers to release apical
exosomes through activation of TLR4 signaling, with the
involvement of activation of the IKK2/SNAP23 exocytic sorting
and let-7 miRNA-mediated gene regulation. Released exosomes
shuttle several antimicrobial peptides, can bind to the C. parvum
sporozoite surface, and display anti-C. parvum activity in vitro and ex
vivo. Our results demonstrate, for the first time, that luminal release
of exosomes is an important component of TLR4-associated
epithelial immune reactions against C. parvum infection.
Results
C. parvum Infection Increases Luminal Release of
Exosomes from the Host Epithelium through Activating
the TLR4/IKK2 Signaling Pathway
Non-malignant human biliary epithelial cells, H69 cells, were
grown to confluence on Percoll inserts to form monolayers; we
detected a few exosome-like microvesicles in the apical side under
electron microscopy (EM) (Figure 1A). These microvesicles were
cup-shaped, with a diameter size about 40–100 nm, typical for
exosomes. When H69 monolayers were exposed to infection by C.
parvum, abundant exosome-like microvesicles were found in the
apical region by the epithelium (Figure 1A). These microvesicles
were morphologically similar to the exosome-like microvesicles
found in non-infected monolayers. Interestingly, MVBs were
detected in the cytoplasm of infected cells. These MVBs usually
contained several exosome-like microvesicles that were morpho-
logically similar to those released to the apical region (Figure 1A).
Using a well-established ultracentrifugation approach [29], we
isolated and purified these exosome-like microvesicles from the
apical supernatants of the H69 monolayers 24h after exposure to
C. parvum infection. These purified microvesicles displayed cup-
shape vesicular characteristics of exosomes, with a diameter size of
40–100 nm under scanning EM. Immunogold staining revealed
that these exosome-like microvesicles were positive for exosome
markers CD63 and ICAM-1 (Figure 1A), and, thus, they were
subsequently referred to as exosomes. Interestingly, these apical
exosomes released from H69 monolayers following infection were
positive for MHC I and MHC II (Figure S1). We then quantified
the release of apical exosomes from H69 monolayers at various
time points after exposure to C. parvum. A time-dependent increase
of apical exosomes was identified using multiple approaches,
including Nanoparticle Tracking Analysis (NTA) [30,31]
(Figure 1B and Figure S1), EM (Figure 1B), and Western blot
for CD63 (Figure S1).
Having determined the increment of apical exosome release
from cell monolayers following C. parvum infection, we then tested
the potential underlying mechanisms. Previous studies demon-
strated that several intracellular signaling pathways are activated
in host epithelial cells following infection, including the TLR4/
IKK/NF-kB and PI-3K pathways [28,32]. Transfection of
epithelial cells with the TLR4-dominant mutant (TLR4-DN) or
treatment of cells with the IKK2 inhibitor SC-514 [33]
significantly inhibited C. parvum-induced exosome release
(Figure 1C). In contrast, an inhibitor of PI-3K showed no effects.
Similarly, exposure of H69 monolayers to LPS (a potent TLR4
ligand) increased release of apical exosomes (Figure S1). Release of
apical exosomes induced by LPS stimulation or C. parvum infection
was also noted in cultured mouse biliary epithelial monolayers
(603B monolayers) and intestinal epithelial monolayers (IEC4.1
monolayers) (Figure S1).
To test C. parvum-induced exosome release in vivo, we applied a
mouse model of biliary cryptosporidiosis through gallbladder
injection of C. parvum oocysts into wild-type and TLR4-deficient
Author Summary
Exosomes are secreted membranous nanovesicles pro-
duced by a variety of cells. Exosomes shuttle various
molecules to transfer them to neighboring or distant cells,
and have been implicated as mediators in cell-cell
communications to modulate physiological and patholog-
ical procedures. Here, we report that luminal release of
exosomal vesicles is an important component of Toll-like
receptor 4 (TLR4)-associated gastrointestinal epithelial
defense against infection by Cryptosporidium parvum, an
obligate intracellular protozoan that infects gastrointesti-
nal epithelial cells. Activation of TLR4 signaling in host
epithelial cells following C. parvum infection promotes
luminal release of epithelial exosomes and exosomal
shuttling of antimicrobial peptides from the epithelium.
By direct binding to the C. parvum surface, exosomal
vesicles reveal anti-C. parvum activity. Activation of TLR4
signaling in epithelial cells after LPS stimulation also
increases exosomal release and exosome-associated anti-C.
parvum activity. Therefore, we speculate that TLR4-
mediated exosome release may be relevant to innate
mucosal immunity in general, representing a new target
for therapeutic intervention for infectious diseases at the
mucosal surface.
Exosomal Anti-C. parvum Activity
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mice [34]. Consistent with our previous results [35], a higher
biliary infection burden was found in TLR4-deficient mice
compared with the wild-type animals (Figure 2A). Intriguingly,
abundant exosomes were detected in the lumen of the biliary tract
from the wild-type animals following infection (Figure 2B and 2C).
Only a few exosomes were detected in the biliary lumen in the
infected TLR4-deficient mice. Taken together, these data suggest
that C. parvum infection increases luminal release of exosomes from
the biliary epithelium, probably through TLR4/IKK2-mediated
activation of the MVB exocytotic pathway.
C. parvum-induced Release of Apical Exosomes from
Biliary Epithelial Cells Involves Rab- and SNAP23-
mediated MVB Exocytosis
To test the contribution of MVB-associated exocytosis in C.
parvum-induced apical exosome release, we performed experiments
using confocal analysis on C. parvum-infected H69 cells. Using
CD63 as the marker for MVBs [2], we detected an increase of
MVBs in the cytoplasm of H69 cells following C. parvum infection
(Figure 3A). The CD63-positive staining showed patchy distribu-
tion in the cytoplasm, with a diameter from 300 to 1,000 nm,
consistent with characteristics of MVBs in cells as shown by EM in
Figure 1A. In addition, these CD63-positive vesicles in the
cytoplasm were overlaying with exosomes labeled with N-
(Lissamine) rhodamine B sulfonyl dioleoylphosphatidylethanola-
mine (N-Rh-PE) [36] (Figure 3B), suggesting that they were
MVBs. Immunostaining revealed positive reactions to Rab11,
Rab27b, and SNAP23 co-localized to the CD63-positive MVBs
(Figure 3C–3E). Of note, accumulation of SNAP23 was obviously
around the MVBs in infected cells (Figure 3E), which was further
confirmed in cells overexpressing SNAP23 (Figure S2). Interest-
ingly, C. parvum-induced SNAP23 localization around MVBs was
not detected in H69 cells stably expressing TLR4-DN (Figure 3F).
To further investigate the role of SNAP23 in C. parvum-induced
exosome release, H69 cells were first treated with an siRNA to
SNAP23, followed by exposure to C. parvum infection for 24 h.
SNAP23 siRNA treatment resulted in a significant decrease in
exosome release from infected H69 monolayers (Figure 4A). H69
cells were infected by C. parvum for various time points, followed by
measurement of total SNAP23 by Western blot and phosphory-
lated SNAP23 by immunoprecipitation (IP). Increased levels of
total SNAP23 (Figure 4B) and phosphorylated SNAP23
(Figure 4C) were detected in infected cells. C. parvum-induced
SNAP23 expression and phosphorylation were not detected in
H69 cells stably expressing TLR4-DN (Figure 4B). Induction of
SNAP23 total protein was detected in mouse biliary epithelial
Figure 1. C. parvum infection increases luminal release of epithelial exosomes through activating the TLR4 signaling pathway. (A)
Infection stimulates luminal release of exosomes (Exs) from H69 monolayers, as assessed by electron microscopy (EM). Abundant exosome-like
microvesicles were observed in the apical region of H69 monolayers following infection (arrowheads in a), with multi-vesicular bodies (MVBs)
detected in the cytoplasm of infected cells (arrow in a). Only a few microvesicles were detected at the apical region of non-infected monolayers (b).
Isolated apical microvesicles are 40–100 nm in size by scanning EM (c) and are positive by immunogold for exosome markers CD63 (d) and ICAM-1
(e). (B) A time-dependent apical exosome release was detected in infected H69 monolayers by nanosight tracking analysis and scanning EM. (C)
Inhibition of TLR4 (by TLR4-DN transfection) and IKK2 (by SC-514), but not PI-3K (by LY294002), blocked C. parvum-induced exosome release. Scale
bars = 100 nm; * p,0.05 ANOVA versus the non-infected controls; # p,0.05 ANOVA versus infected cells.
doi:10.1371/journal.ppat.1003261.g001
Exosomal Anti-C. parvum Activity
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603B cells infected by C. parvum (Figure S3). Upregulation of
SNAP23 and enhanced phosphorylation of SNAP23 were also
detected in H69 cells following LPS stimulation (Figure S3).
Previous studies demonstrated that SNAP23 is a substrate for
IKK2, and phosphorylation of SNAP23 at Ser120 and Ser95 by
IKK2 stimulates fusion of intracellular vesicles to the cell
membrane, promoting exocytosis [37]. Indeed, a direct association
between IKK2 and SNAP23 was evident from IP analysis
(Figure 4D). Increased interaction between IKK2 and SNAP23
was detected in infected cells (Figure 4D). Such observations,
however, do not prove that an IKK2-SNAP23 association is
occurring in MVBs or exosomes or that it is just relevant to these
Figure 2. TLR4-dependent luminal release of exosomes during C. parvum biliary infection in mice. (A) and (B) Luminal release of biliary
exosomes during biliary cryptosporidiosis in the wild type and TLR4-deficient mice. C. parvum oocysts were injected into the gallbladder of wild-type
or TLR4-deficient mice, and liver tissues were collected one week post-injection. Quantitative analysis detected a higher infection burden and a lower
amount of luminal exosome content in TLR4-deficent mice. (C) Abundant exosome-like microvesicles were observed in the luminal region of the wild-
type mice one week post-infection, compared with that in the TLR4-deficent mice by transmission EM (b and d are higher magnifications in a and c,
respectively). Scale bars = 1 mm; * p,0.05 ANOVA versus the wild-type.
doi:10.1371/journal.ppat.1003261.g002
Figure 3. Colocalization of Rab11, Rab27, and SNAP23 to MVBs in epithelial cells following C. parvum infection. (A) and (B)
Visualization of MVBs by CD63 staining and N-Rh-PE labeling. H69 cells were exposed to C. parvum infection for 12 h and stained with CD63 antibody.
CD63 staining showed typical patchy intracellular distribution of MVBs in infected cells (arrows in A). Pre-incubation of cells with N-Rh-PE to label
MVBs followed by C. parvum infection and CD63 staining reveal overlay of CD63 staining with the labeling of newly-formed MVBs (arrows in B). (C)
and (D) Co-localization of Rab11 and Rab27b with MVBs in infected cells (indicated by arrows). H69 cells were exposed to C. parvum infection for 12 h
and co-stained with antibodies to CD63 and Rab11 or Rab27b. (E) and (F) TLR4-dependent co-localization of SNAP23 to MVBs in infected cells. Cells
were exposed to C. parvum for 12 h and co-stained with antibodies to CD63 and SNAP23. C. parvum-induced co-localization of SNAP23 to the MVBs
was detected in H69 cells (arrows in E), but not in cells stably expressing TLR4-DN (F). Scale bars = 5 mm.
doi:10.1371/journal.ppat.1003261.g003
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processes. Together, these data suggest that TLR4 signaling
activates IKK2 to phosphorylate SNAP23 to stimulate exosome
release in cells following C. parvum infection.
miRNAs of the let-7 Family Target SNAP23, and
Downregulation of let-7 miRNAs Is Associated with C.
parvum-induced Exosome Release from Epithelial Cells
miRNAs, such as the let-7 family members, have been
implicated in the regulated exocytotic process [38–40]. Interest-
ingly, several members of the let-7 miRNAs, including let-7i, let-7d,
let-7f, let-7e, and miR-98, showed significant downregulation in
H69 cells following C. parvum infection by array analysis
(Figure 5A), consistent with our previous studies on H69 cells
[27,28]. Decreased expression of let-7i and miR-98 was further
confirmed by Northern blot and real-time PCR analysis in H69
and 603B cells following C. parvum infection (Figure 5A). Consis-
tent with results from our previous studies on LPS-suppressed
expression of let-7 miRNAs in epithelial cells [41], we detected a
decreased expression level of miR-98 in H69 cells following LPS
stimulation (Figure S3). Using in silico database analysis, we found
that there is conserved complementarity between SNAP23 39UTR
and miRNAs of the let-7 family (Figure 5A). To test the potential
targeting of SNAP23 mRNA by let-7 miRNAs, we generated
pMIR-REPORT luciferase constructs containing the SNAP23
39UTR with the putative let-7 binding site (Figure 5B). In addition,
constructs with the CCTC to GGAG for human and ACCT to
TGGA for mouse mutation at the putative binding sites were also
generated as controls. We then transfected H69 cells with these
reporter constructs, followed by assessment of luciferase activity
24 h after transfection. As shown in Figure 5C, a significant
decrease of luciferase activity was detected in cells transfected with
the SNAP23 39UTR construct containing the potential binding
site compared with mutant control vector. No change in luciferase
activity was observed in cells transfected with the mutant SNAP23
39UTR construct, suggesting endogenous translational repression
of the construct with the SNAP23 39UTR. Anti-miRs (anti-miR
miRNA inhibitors) and miRNA precursors are chemically
modified RNA molecules designed to specifically inhibit and
mimic, respectively, endogenous miRNAs [42]. Accordingly, anti-
let-7i markedly increased SNAP23 39UTR-associated luciferase
reporter translation (Figure 5C). In contrast, the miR-98 precursor
significantly decreased the luciferase activity (Figure 5C). Of note,
anti-let-7i and miR-98 precursor only caused a modest alteration
in the luciferase activity, probably due to the targeting of SNAP23
39UTR by other members of the let-7 miRNA family in the cells.
Similar results were also confirmed in 603B cells (Figure 5C).
To test whether miRNA-mediated suppression of SNAP23 is
directly relevant to SNAP23 expression in biliary epithelial cells,
we treated H69 cells with miR-98 precursor or anti-let-7i and then
measured SNAP23 protein level (treated for 48 h) by Western blot
or mRNA level (treated for 24 h) by real-time PCR. Treatment of
cells with the anti-let-7i caused a significant increase in SNAP23
protein content (Figure 6A). Conversely, a decrease in SNAP23
protein level was detected in cells after treatment with the miR-98
precursor (Figure 6A). No significant changes in SNAP23 mRNA
level were detected in cells after treatment with miR-98 precursor
or anti-let-7i (Figure 6A). No significant changes in the phosphor-
ylated SNAP23 level were detected in cells after treatment with the
anti-let-7i (Figure 6B). These data suggest that let-7 family miRNAs
target SNAP23 39UTR, resulting in posttranscriptional suppres-
sion through translation suppression.
To test the impact of let-7 miRNAs on C. parvum-induced
SNAP23 upregulation in H69 cells, we treated cells with the
Figure 4. C. parvum-induced release of apical exosomes from biliary epithelial cells involves TLR4-dependent IKK2-SNAP23
interactions. (A) SNAP23 siRNA inhibits C. parvum-induced release of apical exosomes. H69 monolayers were treated to a non-specific control siRNA
or SNAP23 siRNA, followed by exposure to C. parvum infection for 24 h. Exosomes released into the apical supernatants were isolated and quantified.
(B) and (C) TLR4-dependent induction of SNAP23 expression and its phosphorylation in cells following C. parvum infection, as assessed by Western
blot (B) and immunoprecipitation (IP) analysis (C). C. parvum infection increased total and phosphorylated SNAP23 levels in H69 cells, but not in cells
stably expressing TLR4-DN. (D) C. parvum infection enhances direct interactions between SNAP23 and IKK2. H69 cells were exposed to C. parvum for
24 h, and direct interaction between SNAP23 and IKK2 was measured by IP. * p,0.05 ANOVA versus infected non-specific siRNA control.
doi:10.1371/journal.ppat.1003261.g004
Exosomal Anti-C. parvum Activity
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miR-98 precursor for 48 h and then exposed them to C. parvum for
24 h, followed by Western blot for SNAP23. The miR-98
precursor diminished C. parvum-induced SNAP23 expression
(Figure 6C). Moreover, the miR-98 precursor partially blocked
C. parvum-induced exosome release in H69 cells (Figure 6D).
Interestingly, treatment of cells with the anti-let-7i showed no
significant effects on C. parvum-induced exosome release
(Figure 6D), presumably because of the low level of let-7i in the
infected cells as shown in Figure 5A.
Released Apical Exosomes Display Anti-C. parvum
Activity through Binding to the C. parvum Surface
To investigate the potential effects of released apical exosomes
on C. parvum, we incubated freshly excysted C. parvum sporozoites
with a serial dilution of exosomes isolated from H69 monolayers
after exposure to C. parvum for 24 h. Incubation of C. parvum
sporozoites with isolated exosomes resulted in a decrease in C.
parvum viability in a dose-dependent manner by the viability assay
(Figure 7A). Sporozoites incubated with the exosomes isolated
from non-infected monolayers showed a modest decrease in C.
parvum viability (Figure 7A). Exosomes isolated from the basolat-
eral side of infected H69 monolayers, or apical exosomes from
infected H69 cells expressing TLR4-DN, showed no significant
effects on C. parvum viability (Figure 7A). A decrease in C. parvum
viability was also detected after incubation with apical exosomes
isolated from H69 monolayer following LPS stimulation (Figure
S3). We then incubated the same number of C. parvum sporozoites
with apical exosomes isolated from infected H69 monolayers for
2 h; after extensive washing, these sporozoites were added to H69
cells for infection. A decreased infectivity to host cells for C. parvum
sporozoites after pre-incubation with exosomes was detected,
compared with the sporozoites after incubation with culture
medium, as assessed by real-time PCR (Figure 7B) and immuno-
staining (Figure 7C). Incubation with exosomes from the apical
side of non-infected H69 monolayers, or infected cells stably
expressing TLR4-DN and MyD88-DN, showed no inhibitory
effects on C. parvum sporozoite infectivity (Figure 7B and 7C). A
decreased infectivity of C. parvum sporozoites to intestinal IEC4.1
cells after pre-incubation with exosomes was also detected by real-
time PCR (Figure S4).
Notably, binding of exosomes to the C. parvum sporozoite surface
after incubation with apical exosomes was detected by scanning
EM. In H69 cell cultures after exposure to C. parvum for 2 h, we
observed binding of exosomes to the parasite surface (Figure 8A).
Some of the sporozoites with several exosomes binding to their
surface were dying (showing high electrical density, as indicated by
the asterisk in Figure 8A). To further confirm the direct binding of
exosomes to the C. parvum sporozoite surface, we first labeled
exosomes with the N-Rh-PE as previously reported [36]. Labeled
exosomes were then incubated with freshly excysted C. parvum
sporozoites, followed by observation under confocal microscopy.
Fluorescent activity was detected in these sporozoites incubated
with the labeled exosomes (Figure 8B). No detectable fluorescent
activity was observed in the sporozoites incubated with the non-
labeled exosomes.
Direct interactions between the Gal/GalNAc-containing glyco-
proteins on the epithelial cell apical membrane surface and Gal/
GalNAc-ligand molecules on the C. parvum sporozoite surface have
been implicated to mediate the attachment of C. parvum sporozoites
to host cells [25]. The Gal/GalNAC-specific lectin PNA can
markedly decrease the infection [43,44]. We found that isolated
apical exosomes carry Gal/GalNAc molecules (recognized by
PNA), displaying positive reactions to PNA blotting at the
epithelial apical membrane (Figure 8C). Interestingly, blotting of
whole lysates of C. parvum sporozoites after pre-incubation with
isolated exosomes revealed a positive reaction to exosome marker
Figure 5. The let-7 miRNAs target SNAP23 and are downregulated in epithelial cells following C. parvum infection. (A) C. parvum
infection downregulates expression of the let-7 miRNA family. H69 cells were exposed to C. parvum infection for 12 h, followed by miRNA analysis
using mercury LNA array, Northern blot, and real-time PCR. A heat map of the let-7 miRNA family is shown and expression levels are presented as the
log2 (Hy
5/Hy3) ratios. Representative Northern blot for let-7/miR-98 in H69 and 603B cells and real-time PCR quantification of miR-98 in H69 cells are
shown. (B) The schematic of SNAP23 mRNA showed a potential binding site in its 39UTR for the let-7 miRNA family in humans and in mice. The
SNAP23 39UTR sequence covering the potential binding sites for the let-7 miRNA family was inserted into the pMIR-REPORT luciferase plasmid. A
control plasmid with the mutant 39UTR sequence was also generated for control. (C) Binding of let-7/miR-98 miRNAs to the potential binding site in
the SNAP23 39UTR results in translational suppression. Cells were transfected with the pMIR-REPORTER luciferase constructs and treated with anti-
miRs or precursors to miR-98, or non-specific oligo control, for 24 h, followed by luciferase analysis. *, p,0.05 ANOVA versus the non-infected control
(in A) or empty vector control (in C); #, p,0.05 ANOVA versus the control precursor or control anti-miR (in C).
doi:10.1371/journal.ppat.1003261.g005
Exosomal Anti-C. parvum Activity
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CD63 (Figure 8D). Moreover, pre-incubation of isolated exosomes
with PNA (followed by extensive washing and ultracentrifugation
to clear out unbound/free PNA) abolished the inhibitory effects of
exosomes on C. parvum viability (Figure 8E). The above data
indicate that apical exosomes released from C. parvum-infected
biliary epithelium possess anti-C. parvum capacity. Interestingly,
exosomes isolated from C. parvum-infected H69 monolayers
showed no detectable inhibitory effects on the viability of the
K12 strain E. coli after incubation in vitro (Figure S5).
Apical Exosomes Released from C. parvum-infected
Biliary Epithelium Carry Antimicrobial Peptides, a Process
that Is Mediated by TLR4 Signaling
Production of antimicrobial peptides, such as beta-defensins and
cathelicidins, is a major element for TLR-mediated epithelial anti-
C. parvum defense [19,25,45]. Increasing amounts of human beta-
defensin 2 (HBD2) and cathelicidin-37 (LL-37) were detected by
ELISA in apical exosomes isolated from C. parvum-infected H69
monolayers, compared with those isolated from non-infected cells
(Figure 9A). In contrast, no increase in HBD2 and LL-37 contents
was detected in the isolated exosomes from infected H69 cells
stably expressing TLR4-DN (Figure 9A). Exosomal shuttling of
HBD2 and LL-37 was further confirmed by immunogold staining,
using the apical exosomes isolated from C. parvum-infected H69
monolayers (Figure 9B and 9C). Unfortunately, we have been
unable to achieve efficient exosome preparations to demonstrate
that the antimicrobial peptides in the exosomes are biochemically
active. Therefore, to elucidate whether exosomal shuttle of HBD2
and LL-37 accounts for the anti-C. parvum activity of these isolated
exosomes from C. parvum-infected cells, we performed the gain-
and loss-of-function experiments through overexpression or
knockdown of HBD2 and LL-37 in H69 cells. These cells were
then infected with C. parvum for 24 h, and the released exosomes
were isolated and then incubated with freshly excysted C. parvum
sporozoites. Of note, pre-incubation of sporozoites with the
exosomes isolated from cells overexpressing HBD2 and LL-37
resulted in a significant decrease in parasite infectivity (Figure 9D).
This is probably due to an increased sorting of antimicrobial
peptides into the exosomes in these cells at the basal condition.
Moreover, after incubation with exosomes isolated from C. parvum-
infected H69 cells overexpressing HBD2 and LL-37, C. parvum
sporozoites showed a further decrease in infectivity (Figure 9D). In
contrast, incubation with exosomes isolated from C. parvum-
infected H69 cells with knockdown of HBD2 and LL-37 showed
no significant effects on the infectivity of C. parvum sporozoites
(Figure 9E and 9F). These data suggest that antimicrobial peptides
Figure 6. Downregulation of let-7 miRNAs is associated with C. parvum-induced exosome release from epithelial cells. (A) Functional
manipulation of let-7/miR-98 causes reciprocal alterations in SNAP23 expression at the mRNA and protein levels. H69 cells were treated with various
doses of let-7i precursor or anti-let-7i for 24 h, followed by Western blot for SNAP23 protein (upper panel) and real-time PCR of SNAP23 mRNA (lower
panel). Whereas a significant decrease or increase in SNAP23 protein content was detected in cells treated with let-7i precursor or anti-let-7i,
respectively, no changes in SNAP23 mRNA levels were observed in the treated cells. (B) Anti-let-7i shows no effect on the phosphorylation of SNAP23
in H69 cells. Cells were treated with anti-let-7i for 24 h, followed by IP for phosphorylated SNAP23. (C) Overexpression of let-7i blocks C. parvum-
induced upregulation of SNAP23. H69 cells were transfected with let-7i precursor for 48 h and then exposed to C. parvum infection for 24 h.
Expression of SNAP23 was measured by real-time PCR and Western blot. (D) Functional manipulation of let-7i causes alterations in C. parvum-induced
release of apical exosomes. H69 monolayers were treated with a non-specific anti-miR control or anti-let-7i or let-7i precursor, followed by exposure to
C. parvum infection for 24 h. Exosomes released into the apical supernatants were isolated and quantified. Data are averages of three independent
experiments. *, p,0.05 ANOVA versus the non-infected control; #, p,0.05 ANOVA versus the control anti-miR.
doi:10.1371/journal.ppat.1003261.g006
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HBD2 and LL-37 in apical exosomes that are released from
epithelial cells contribute to mucosal immune defense in response
to C. parvum infection.
Discussion
One of the major findings of this study is that activation of
TLR4 signaling increases luminal release of exosomes from the
biliary epithelium during C. parvum infection. Whereas a basal level
of exosomal luminal release exists in cultured biliary epithelial
monolayers and in the murine biliary tract, a TLR4-dependent
increase in luminal release of epithelial exosomes was detected
following C. parvum infection. Release of exosomes to the
extracellular environment involves fusion of MVBs with the
plasma membrane. Intracellular trafficking and fusion of com-
partments classically require small GTPases of the Rab family [2].
Further supporting this concept and consistent with results from
previous reports on induced exosome release [17], we detected a
significant co-localization of Rab11 and Rab27b with MVBs in the
cytoplasm of epithelial cells following C. parvum infection. Besides
Rab11 and Rab27b, we identified that SNAP23 may regulate the
fusion of MVBs with the plasma membrane required for exosome
release. C. parvum infection increases the protein content of total
SNAP23 and enhances phosphorylation of SNAP23 in infected
cells. Intriguingly, activation of TLR4 may contribute to both
events: TLR4 signaling increases SNAP23 protein expression
through modulation of let-7-mediated gene regulation, and
stimulates SNAP23 phosphorylation through activation of IKK2.
We previously demonstrated TLR4/NF-kB-dependent downreg-
ulation of let-7 family miRNAs in C. parvum-infected biliary
epithelial cells [27,41]. Targeting of the 39UTR of SNAP23 by let-
7 family miRNAs resulted in translational suppression. Functional
manipulation of let-7i caused reciprocal alterations in cellular
SNAP23 protein content. Indeed, overexpression of let-7 miRNA
members attenuated C. parvum-induced SNAP23 expression and
exosome release from the biliary epithelium. In addition, C.
parvum-induced phosphorylation of SNAP23 is dependent on
TLR4 signaling. Knockdown of TLR4 blocked C. parvum-induced
phosphorylation of SNAP23 in infected cells and, consequently,
exosome release into the supernatants. Our data were supported
by a recent report showing that SNAP23 is a substrate for IKK2
[37]. Phosphorylation of SNAP23 at Ser120 and Ser95 by IKK2
stimulates fusion of intracellular vesicles to the cell membrane,
promoting exocytosis [37]. The next challenge will be to examine
in greater depth the involvement of TLR4 signaling in C. parvum-
induced co-localization of Rab11 and Rab27b with MVBs, and to
determine the magnitudes of miRNA-mediated SNAP23 expres-
sion versus its phosphorylation in TLR4-regulated exosome
release.
Another key point from this study is that released exosomes
shuttle antimicrobial peptides and display anti-C. parvum capacity,
thus contributing to mucosal anti-C. parvum defense. It has been
reported that antimicrobial peptides, such as HBD2 and LL-37,
are present in breast milk and provide protection for maternal
breast tissue and the developing digestive tracts of newborns [46].
Additionally, antimicrobial peptides were identified in cervical-
vaginal fluid, suggesting their involvement in extracellular
immunology [47]. Notably, exosomes have been reported in
Figure 7. Apical exosomes released from C. parvum-infected biliary epithelium display anti-C. parvum activity. (A) Effects of incubation
with isolated exosomes from the biliary epithelium on C. parvum viability. Exosomes were isolated from the basolateral or apical supernatants of H69
monolayers of non-infected control, cells of C. parvum infection for 24 h, and cells stably expressing TLR4-DN after infection for 24 h. Freshly excysted
C. parvum sporozoites were incubated with isolated exosomes (as indicated) for 2 h, and parasite viability was assessed by propidium iodide staining.
(B) and (C) Effects of incubation with isolated apical exosomes from the biliary epithelium on the infectivity of C. parvum sporozoites. The same
number of freshly excysted C. parvum sporozoites was incubated with exosomes isolated from H69 or 603B monolayers for 2 h and then added to
H69 cells for 2 h. Parasite infection burden was measured by real-time PCR (B) and fluorescence microscopy (C). Pre-incubation of isolated exosomes
abolished their inhibitory effects on C. parvum infectivity. C. parvum parasites were stained in green using a specific antibody and cell nuclei in blue
by DAPI. Scale bars = 5 mm; *, p,0.05 ANOVA versus medium control.
doi:10.1371/journal.ppat.1003261.g007
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breast milk and cervical-vaginal fluid [1,2]. The anti-C. parvum
activity of HBD2 was previously reported in intestinal and biliary
cryptosporidiosis [19,45]. Here, we identified shuttling of both
HBD2 and LL-37 in the apical exosomes released from H69
monolayers. An increase in HBD2 and LL-37 content was detected
in the apical exosomes from infected cells, and inhibition of TLR4
signaling decreased their exosomal content. Because these exosomes
display a protein profile different from the whole cell lysate,
targeting of cytoplasmic proteins to the MVBs within epithelial cells,
such as HBD2 and LL-37, must be controlled through highly
selective and regulated mechanisms. However, how TLR4 signaling
regulates targeting of antimicrobial peptides to MVBs in epithelial
cells remains largely unknown. One additional unanswered
question is whether shuttling of MHC proteins in the apical
exosomes contributes to antigen presentation.
Anti-C. parvum activity of apical exosomes released from the
epithelium may involve direct binding to the C. parvum sporozoite
surface. Morphologically, direct binding of exosomes to the C.
parvum sporozoite surface was evident by scanning and transmis-
sion EM observations. Confocal analysis with exosomal labeling
confirmed the delivery of exosomal content to C. parvum
sporozoites after incubation. It is not clear what mechanisms are
responsible for this exosome binding/targeting. The infection
process of epithelial cells by C. parvum is initiated by the attachment
of the parasite to the plasma membrane of host epithelial cells
[25]. Unidentified specific molecules on the surface of both
epithelial cells and C. parvum sporozoites mediate this attachment
process [43]. Gal/GalNAc epitopes of glycoproteins on the
epithelial apical membrane and Gal/GalNAc-specific sporozoite
surface lectins are involved in the mechanism(s) of C. parvum
attachment to intestinal and biliary epithelial cells [43,44]. As
expected, treatment of exosomes with Gal/GalNAc-specific PNA
lectin diminished their anti-C. parvum activity, suggesting that these
molecules may be involved, at least partially, in exosomal binding
Figure 8. Gal/GalNAc-associated molecules mediate direct binding of exosomes to the C. parvum surface. (A) Direct binding of apical
exosomes to the C. parvum surface observed under EM. When sporozoites were added to H69 cells for 2 h, exosome-like microvesicles on their
surface were observed, as evident by SEM (arrows in a and b; b shows a higher magnification of the boxed region in a). The TEM image shows a dying
C. parvum parasite that was invading an epithelial cell with several exosomes binding to its surface (arrows in c). (B) Delivery of exosomal content to
C. parvum sporozoites after incubation. Isolated exosomal vesicles were labeled with the N-Rh-PE dye, and after extensive washing, were incubated
with C. parvum sporozoites for 2 h. These sporozoites showed positive labeling of the dye after incubation. Parasite nuclei were labeled in blue with
DAPI (arrows). (C) Gal/GalNAc-associated molecules in H69 apical membrane fraction and exosomes released from H69 monolayers. Positive bands
were detected in both H69 apical membrane fraction and released exosomes using SDS gel lectin-blotting with the Gal/GalNAc-specific lectin PNA.
(D) Blotting of whole lysates of C. parvum sporozoites after pre-incubation with isolated exosomes revealed a positive reaction to exosome marker
CD63. (E) PNA attenuates the inhibitory effects of exosomes on C. parvum viability. Pre-incubation of isolated exosomes abolished their inhibitory
effects on C. parvum viability. Scale bars = 1 mm; *, p,0.05 ANOVA versus medium control.
doi:10.1371/journal.ppat.1003261.g008
Exosomal Anti-C. parvum Activity
PLOS Pathogens | www.plospathogens.org 9 April 2013 | Volume 9 | Issue 4 | e1003261
to the C. parvum sporozoite surface. The lifecycle of C. parvum, both in
vitro and in vivo, has extracellular stages (i.e., sporozoites, merozoites,
and microgametocytes) [25], and they are vulnerable to exosomal
binding/targeting. Therefore, luminal release of exosomes from
epithelial cells may represent an important element of TLR-
mediated mucosal anti-C. parvum defense. Surprisingly, it appears
that released exosomes have no significant effect on the viability of
the K12 strain E. coli. One possibility is that the membrane structure
of E. coli may not favor direct exosomal binding.
In addition, increased exosomal release and exosome-associated
anti-C. parvum activity were detected in biliary epithelial cells after
LPS stimulation. Therefore, TLR4-mediated exosome release may
be relevant to innate mucosal immunity in general. Overall, our data
suggest that activation of TLR4 signaling stimulates the biogenesis
and luminal release of antimicrobial peptide-shuttling exosomes and
contributes to gastrointestinal mucosal anti-C. parvum defense. Such a
process may be explored for therapeutic intervention. Luminal
release of exosomes may also mediate the function of distant cells
along the gastrointestinal tract, or regulate the homeostasis of gut
microbiota, through delivery signaling molecules.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health under the Assurance of
Compliance Number A3348-01. All animal experiments were done
in accordance with procedures (protocol number # 0868) approved
by the Institutional Animal Care and Use Committee of the
Creighton University School ofMedicine. All surgery was performed
under ketamine and xylazine anesthesia, and all efforts were made to
minimize suffering.
C. parvum and Cell Lines
C. parvum oocysts of the Iowa strain were purchased from a
commercial source (Bunch Grass Farm, Deary, ID). Before
infecting cells, oocysts were excysted to release infective sporozo-
ites as previously described [19]. H69 cells (a gift from Dr. D.
Jefferson, Tufts University,) are SV40-transformed normal human
biliary epithelial cells originally derived from normal liver
harvested for transplant [19,27]. 603B cells are immortalized
normal mouse biliary epithelial cells (a gift from Dr. Y. Ueno,
Tohoku University School of Medicine, Japan). Murine intestinal
epithelial cell line (IEC4.1) was a kind gift from Dr. Pingchang
Yang (McMaster University, Hamilton, Canada).
Plasmids and Reagents
TLR4-DN mutant was kindly provided by Dr. M. F. Smith
(University of Virginia) and MyD88-DN was a gift from Prof. J.
Tschopp (University of Lausanne, Switzerland). Cells stably
Figure 9. Apical exosomes released from infected cells carry antimicrobial peptides, a process mediated by TLR4 signaling. (A)
Apical exosomes released from C. parvum-infected H69 monolayers carry antimicrobial peptides in a TLR4-dependent manner. Monolayers of H69
cells and cells stably expressing TLR4-DN were exposed to C. parvum for 24 h, and apical exosomes were collected and purified. The content of beta-
defensin 2 (HBD2) and cathelicidin 37 (LL-37) in these isolated exosomes was assessed by ELISA. (B) and (C) Existence of HBD2 (B) and LL-37 (C) in
apical exosomes from infected H69 monolayers as confirmed by immunogold. Non-specific anti-IgG was used as the control for immunogold. (D)–(F)
Functional manipulation of HBD2 and LL-37 expression in H69 cells influences the anti-C. parvum activity of their released exosomes by C. parvum
infection. H69 cells were transfected with the full lengths of HBD2 or LL-37, or siRNAs to HBD2 or LL-37. Cells were then exposed to C. parvum
infection for 24 h and apical exosomes were isolated. These vesicles were then incubated with freshly excysted C. parvum sporozoites for 2 h, and
after extensive washing, the sporozoites were added to H69 cells for infection. Parasite infection burden was measured by real-time PCR (D and E)
and fluorescent microscopy (F). C. parvum parasites were stained in green and cell nuclei in blue. Scale bars = 100 nm (in B and C) and 5 mm (in F);
*, p,0.05 ANOVA versus the non-infected control; #, p,0.05 ANOVA versus the infected H69 cells.
doi:10.1371/journal.ppat.1003261.g009
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expressing TLR4-DN or MyD88-DN were established as previ-
ously reported [19]. Primers used to amplify the open reading
frame of human SNAP23 (NM_130798) were: 59-GTCATGGA-
TAATCTGTCATCAGAAGAAAT-39 (forward) and 59-TTA-
GCTGTCAATGAGTTTCTTTGCTC-39 (reverse). PCR prod-
ucts were cloned into pcDNA3.3-TOPO vector (Invitrogen).
Primers used to amplify the open reading frame of human beta-
defensin 2 (NM_004942) and cathelicidin-37 (NM_004345) were:
59-CAAGCTTCGATGAGGGTCTTGTATCTCCTCTTCTC-
39 (beta-defensin 2 forward) and 59-CGGATCCTGGCTTTT-
TGCAGCATTTTG-39 (beta-defensin 2 reverse) and 59-CAA-
GCTTCGGCTATGGGGACCATGAAGACCC-39 (cathelici-
din-37 forward) and 59-CGGATCCGGACTCTGTCCTGGG-
TACAAGATTC-39 (cathelicidin-37 reverse). PCR products were
cloned into the HindIII and BamH I sites of the pEGFPN3 vector
(Invitrogen). WGA and PNA lectins were purchased from Sigma.
Infection Models and Infection Assays
Models of human biliary cryptosporidiosis using H69 and 603B
cells were employed as previously described [19,27,28,41,43].
Infection was done in a culture medium consisting of DMEM-F12,
100 U/ml penicillin, 100 mg/ml streptomycin, and freshly excyst-
ed sporozoites (from oocysts in a 3:1 ratio with host cells). All
excysted sporzoite preparations were tested to exclude LPS
contamination using the Limulus Amebocyte Lysate (LAL) gel
formation test [48]. Inactivated organisms (treated at 65uC for
30 min) were used for the non-infected controls and experiments
were performed in triplicate.
For in vivo biliary infection, C57BL/6 wild-type mice and
TLR4-deficient (C57BL/10ScNJ; Tlr4lps-del/Tlr4lps-del genotype)
mice were obtained from Jackson Laboratories. C. parvum oocysts
were directly injected into the gallbladder of C57BL/6J or TLR4-
deficient mice, as previously reported [32,33]. C. parvum infection
and exosome release in the intrahepatic bile ducts were observed
one week post-injection. Five animals from each group were
sacrificed and livers were obtained for immunohistochemistry and
electron microscopy.
Real-time PCR, immunofluorescence microscopy, and immu-
nohistochemistry were used to assay C. parvum infection as
previously reported [17,27,28,41,43]. Primers specific for C.
parvum 18s ribosomal RNA (forward: 59-TAGAGATTG-
GAGGTTGTTCCT-39, and reverse: 59-CTCCACCAACTAA-
GAACGGCC-39) were used to amplify the cDNA specific to the
parasite. For immunofluorescence microscopy, cells were fixed
with 2% paraformaldehyde and incubated with a polyclonal
antibody against C. parvum [19], followed by anti-rabbit FITC-
conjugated secondary antibody and co-stained with 4,6-diami-
dino-2-phenylindole (DAPI) (Molecular Probes). The liver tissues
were stained with H&E, and parasite burden in the biliary tree was
performed by counting all intracellular parasite stages in identified
bile ducts, as previously reported [35].
Exosome Purification and Nanoparticle Tracking Analysis
(NTA)
Supernatant medium from the apical reservoir of the Percoll
inserts was collected at the indicated time points after infection.
Medium was then harvested and centrifuged at 1000 rpm for
10 min to eliminate cells and again spun at 10,000 rpm for
30 min, followed by filtration through 0.22 mm filter to remove
cell debris. Exosomes were pelleted by ultracentrifugation (Beck-
man Ti70 rotor) at 44,000 rpm for 70 min and precipitated using
exosome precipitation solution (Exo-Quick; System Bioscience)
following the manufacturer’s instructions. Exosomes were further
quantified by the NTA analysis using a Nanosight (model NS500),
as previously reported [30,31].
Immunofluorescence and Electron Microscopy (EM)
Cell cultures were fixed with 4% paraformaldehyde and
incubated with antibodies (Santa Cruz) to SNAP23, CD63,
Rab11, and Rab27, followed by treatment with Alexa Fluor
594–conjugated anti-rabbit secondary antibody (1:100; Invitro-
gen). Cell cultures were then mounted in Slow Fade anti-fade
reagent with DAPI (Molecular Probes). Images were captured
using an inverted fluorescence microscope TE2000-E (Nikon).
EM was performed as previously described [24]. Briefly, for
transmission EM, exosome pellets were resuspended in 2.5%
glutaraldehyde, embedded with a mixture of 4% uranyl acetate
and 2% methylcellulose (1:9 ratio), and observed with a JEOL
1400 electron microscope (JEOL USA). For scanning EM,
isolated exosomes were fixed immediately in 2.5% glutaralde-
hyde, dehydrated, dried in a critical point drying device, sputter
coated, and examined with a Hitachi S-4700 microscope
(Hitachi). For immunogold analysis, exosomes were fixed in 4%
paraformaldehyde, blocked with 10% FCS-PBS for 20 min, and
incubated overnight at 4uC with antibodies to CD63 (Santa
Cruz), ICAM-1 (Santa Cruz), LL-37 (Hycult Biotech), or HBD2
(Alpha Diagnostic). After incubation with the secondary antibod-
ies, samples were labeled with protein A-10-nm gold, embedded,
and observed with a JEOL 1400 electron microscope. Transmis-
sion EM of mouse liver tissues was performed as previously
reported [24].
siRNA, Anti-miRs, and miRNA Precursors
siRNAs to SNAP23, LL-37 and HBD2, and negative control
oligos (Dharmacon) were used at a concentration of 10 nM and
transfected with Lipofectamine RNAimax according to the
manufacturer’s protocol (Invitrogen). Anti-miRs and miRNA
precursors (Ambion) were used to manipulate miRNA function
in cells, as previously reported [27,28,41].
Luciferase Reporter Constructs and Luciferase Assay
Complementary 39 bp for human and 33 bp for mouse DNA
oligonucleotides containing the putative let-7 family miRNAs
target site within the 39UTR of human SNAP23 (Human-Sense:
59-ctag ACATGAATTCAGATTTACCTCAATGCTAAGAAT-
TA-39; Human-antisense:59-agct TAATTCTTAGCATTGAGG-
TAAATCTGAATTCATGT-39; Mouse-Sense: 59-ctag CATGT-
GAATTCAGATTTACCTCAATACTA-39; Mouse-antisense:59-
agct TAGTATTGAGGTAAATCTGAATTCACATG-39) were
cloned into the multiple cloning site of the pMIR-REPORT
Luciferase vector (Ambion). Another pMIR-REPORT Luciferase
construct containing mutant 39UTR (CCTC to GGAG for
human; ACCT to TGGA for mouse) was also generated as a
control. Transfection and assessment of luciferase activity were
performed as previously reported [27,28,41].
Accession Numbers
The mRNA sequence data for genes described in this study can
be found in the NCBI under the following accession numbers:
Homo sapiens CD63 (NM_001257389), Mus musculus CD63
(NM_001042580); Homo sapiens TLR4 (NM_001257389), Mus
musculus TLR4 (NM_025817); Homo sapiens Rab27b (NM_004163),
Mus musculus Rab27b (NM_030554); Homo sapiens MyD88
(NM_001172566), Mus musculus MyD88 (NM_010851); Homo
sapiens IKK2 (NM_001190720), Mus musculus IKK2 (NM_
001159774); Homo sapiens Rab11 (NM_014904), Mus musculus
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Rab11 (NM_017382); Homo sapiens SNAP23 (NM_003825), Mus
musculus SNAP23 (NM_001177792); Homo sapiens let-7i (NR_
029661), Mus musculus let-7i (NR_029527); Homo sapiens miR-98
(NR_029513), Mus musculus miR-98 (NR_029753); Homo sapiens
HBD2 (NM_004942); Homo sapiens LL-37 (NM_004345), Mus
musculus LL-37 (NM_009921).
Supporting Information
Figure S1 Nanosight Tracking Analysis (NTA), Western
blot for CD63 and MHC proteins, and release of apical
exosomes from monolayers of different epithelial cell
types following C. parvum infection or LPS stimulation.
(A) Size and particle distribution plots of isolated apical exosomes
from the non-infected and C. parvum-infected (12 h) H69
monolayers by NTA. Both plots show a peak size around
100 nm for these isolated exosomes. Of note, the concentration
scores for exosomes from non-infected and infected monolayers
are different. Insert images are the representative screenshots of
isolated exosomes by NTA. Image size recorded by video is
approximately 100 nm. (B) Increased exosome release to the
apical region following C. parvum infection was also confirmed by
Western blot for CD63. (C) Increased amounts of MHC I and
MHC II were detected in both the apical and basolateral
exosomes released from H69 monolayers following infection. (D)
Release of apical exosomes from monolayers of different
epithelial cell types following C. parvum infection or LPS
stimulation. Cells were grown to form monolayers on the Percoll
inserts and then exposed to C. parvum infection for 24 h or LPS
stimulation for 12 h. Exosomes were isolated from the apical
supernatants and assessed by Western blot for CD63 (upper
panel) and NTA (lower panel). *, p,0.05 ANOVA versus the
non-infected controls.
(TIF)
Figure S2 Association of SNAP23 with MVBs in H69
cells overexpressing SNAP23. H69 cells were transfected with
the SNAP23 plasmid and then exposed to C. parvum infection for
12 h. Cells were stained with CD63 antibody. Accumulation of
SNAP23 around CD-63-positive multi-vesicular bodies was
obvious as assessed by confocal microscopy. Scale bars = 5 mm.
(TIF)
Figure S3 Expression of SNAP23 and phosphorylation of
SNAP23 in 603B cells following C. parvum infection, and
epithelial expression of miR-98 and anti-C. parvum
activity of isolated exosomes from H69 monolayers after
LPS stimulation. Cells were grown to form monolayers on the
Percoll inserts and then exposed to C. parvum infection or LPS
stimulation. SNAP23 expression and its phosphorylation were
assessed by Western blot and IP analysis (A and B). Expression of
miR-98 was quantified by real-time PCR (C), and viability of C.
parvum sporozoites after incubation with isolated exosomes was
measured by epifluorescence microscopy (D). *, p,0.05 ANOVA
versus the medium control.
(TIF)
Figure S4 Anti-C. parvum activity of isolated exosomes
from IEC4.1 monolayers following C. parvum infection.
Cells were grown to form monolayers on the Percoll inserts and
then exposed C. parvum infection for 24 h. Released apical
exosomes were collected and purified. These exosomes were then
incubated with freshly excysted C. parvum sporozoites for 2 h, and
after extensive washing, the sporozoites were added to IEC4.1 cells
for infection. Parasite infection burden was measured by real-time
PCR. *, p,0.05 ANOVA versus the medium control.
(TIF)
Figure S5 Viability of E. coli K12 strain after incubation
with isolated apical exosomes from C. parvum-infected
H69 monolayers. K12, a laboratory strain of E. coli susceptible
to all antimicrobial drug classes, was incubated with apical
exosomes isolated from non-infected or C. parvum-infected H69
monolayers. OD600 measurements were taken every 60 min for a
total of 5 h. Recombinant human LL-37 was used as the positive
control and phosphate buffered saline was used as a negative
control. These viability measurements were substantiated by
performing plate counts collected at each time point.
(TIF)
Text S1 Details of Western blot, real-time PCR, North-
ern blot, ELISAs, immunoprecipitation (IP), C. parvum
viability assay, E. coli viability experiments, and
statistical analysis of data.
(DOC)
Acknowledgments
We thank Drs. Rui Zhou, Xiaoqing Li, Alex N. Eischeid, Jun Liu, and Jian
Zhao for helpful and stimulating discussions, and Barbara L. Bittner for her
assistance in writing the manuscript. H69 cells were from Dr. D. Jefferson
(Tufts University, Boston, MA), 603B cells were from Dr. Y. Ueno (Tohoku
University, Sendai, Japan), and the IEC4.1 cells were from Dr. Pingchang
Yang (McMaster University, Hamilton, Canada).
Author Contributions
Conceived and designed the experiments: GH AYG ALR NDH XMC.
Performed the experiments: GH AYG ALR BQH. Analyzed the data: GH
AYG ALR NDH XMC. Contributed reagents/materials/analysis tools:
HDW GZ NFL. Wrote the paper: GH XMC.
References
1. Cocucci E, Racchetti G, Meldolesi J (2009) Shedding microvesicles: artefacts no
more. Trends Cell Biol 19:43–51.
2. Thery C, Ostrowski M, Segura E (2009) Membrane vesicles as conveyors of
immune responses. Nat Rev Immunol 9:581–593.
3. Fabbri M, Paone A, Calore F, Galli R, Gaudio E, et al. (2012) MicroRNAs bind
to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl
Acad Sci USA 109:E2110–2116.
4. Segura E, Nicco C, Lombard B, Ve´ron P, Raposo G, et al. (2005) ICAM-1 on
exosomes from mature dendritic cells is critical for efficient naive T-cell priming.
Blood 106:216–223.
5. Abusamra AJ, Zhong Z, Zheng X, Li M, Ichim TE, et al. (2005) Tumor
exosomes expressing Fas ligand mediate CD8(+) T-cell apoptosis. Blood Cell
Mol Dis 35:169–173.
6. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA,
Hopmans ES, et al. (2010) Functional delivery of viral miRNAs via exosomes.
Proc Natl Acad Sci USA 107: 6328–6333.
7. Vlassov AV, Magdaleno S, Setterquist R, Conrad R (2012) Exosomes: current
knowledge of their composition, biological functions, and diagnostic and
therapeutic potentials. Bba-Gen Subjects 1820:940–948.
8. O’Loughlin AJ, Woffindale CA, Wood MJ (2012) Exosomes and the
emerging field of exosome-based gene therapy. Curr Gene Ther 12:262–
274.
9. Epple LM, Griffiths SG, Dechkovskaia AM, Dusto NL, White J, et al. (2012)
Medulloblastoma exosome proteomics yield functional roles for extracellular
vesicles. PLoS One 7:e42064.
10. Johnstone RM, Bianchini A, Teng K (1989) Reticulocyte maturation and
exosome release: transferrin receptor containing exosomes shows multiple
plasma-membrane functions. Blood 74:1844–1851.
11. Escola JM, Kleijmeer MJ, Stoorvogel W, Griffith JM, Yoshie O, et al. (1998)
Selective enrichment of tetraspan proteins on the internal vesicles of
multivesicular endosomes and on exosomes secreted by human B-lymphocytes.
J Biol Chem 273: 20121–20127.
Exosomal Anti-C. parvum Activity
PLOS Pathogens | www.plospathogens.org 12 April 2013 | Volume 9 | Issue 4 | e1003261
12. Atay S, Gercel-Taylor C, Suttles J, Mor G, Taylor DD (2011) Trophoblast-
derived exosomes mediate monocyte recruitment and differentiation.
Am J Reprod Immunol 65: 65–77.
13. Buning J, von Smolinski D, Tafazzoli K, Zimmer KP, Strobel S, et al. (2008)
Multivesicular bodies in intestinal epithelial cells: responsible for MHC class II-
restricted antigen processing and origin of exosomes. Immunology 125:510–521.
14. Bhatnagar S, Schorey JS (2007) Exosomes released from infected macrophages
contain Mycobacterium avium glycopeptidolipids and are proinflammatory. J Biol
Chem 282:25779–25789.
15. Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, et al. (2012) Syndecan-
syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 14:677–685.
16. Sudhof TC, Rothman JE (2009) Membrane fusion: grappling with SNARE and
SM proteins. Science 323:474–477.
17. Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, et al. (2010)
Rab27a and Rab27b control different steps of the exosome secretion pathway.
Nat Cell Biol 12:19–U61.
18. Sansonetti PJ (2004) War and peace at mucosal surfaces. Nat Rev Immunol
4:953–964.
19. Chen XM, O’Hara SP, Nelson JB, Splinter PL, Small AJ, et al. (2005) Multiple
TLRs are expressed in human cholangiocytes and mediate host epithelial
defense responses to Cryptosporidium parvum via activation of NF-kappaB.
J Immunol 175:7447–7456.
20. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate
immunity: update on Toll-like receptors. Nat Immunol 11:373–384.
21. Mallegol J, Van Niel G, Lebreton C, Lepelletier Y, Candalh C, et al. (2007)
T84-intestinal epithelial exosomes bear MHC class II/peptide complexes
potentiating antigen presentation by dendritic cells. Gastroenterology
132:1866–1876.
22. van Niel G, Raposo G, Candalh C, Boussac M, Hershberg R, et al. (2001)
Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology
121:337–349.
23. Chen X, Song CH, Feng BS, Li TL, Li P, et al. (2011) Intestinal epithelial cell-
derived integrin alphabeta6 plays an important role in the induction of
regulatory T cells and inhibits an antigen-specific Th2 response. J Leukoc Biol
90:751–759.
24. Masyuk AI, Huang BQ, Ward CJ, Gradilone SA, Banales JM, et al. (2010)
Biliary exosomes influence cholangiocyte regulatory mechanisms and prolifer-
ation through interaction with primary cilia. Am J Physiol-Gastr L 299:G990–
G999.
25. Chen XM, Keithly JS, Paya CV, LaRusso NF (2002) Current concepts:
cryptosporidiosis. New Engl J Med 346:1723–1731.
26. Ambros V (2001) microRNAs: Tiny regulators with great potential. Cell
107:823–826.
27. Chen XM, Splinter PL, O’Hara SP, LaRusso NF (2007) A cellular micro-RNA,
let-7i, regulates toll-like receptor 4 expression and contributes to cholangiocyte
immune responses against Cryptosporidium parvum infection. J Biol Chem
282:28929–28938.
28. Zhou R, Hu G, Liu J, Gong AY, Drescher KM, et al. (2009) NF-kappaB p65-
dependent transactivation of miRNA genes following Cryptosporidium parvum
infection stimulates epithelial cell immune responses. PLoS Pathog 5:e1000681.
29. Valadi H, Ekstromk, Bossios A, Sjo¨strand M, Lee JJ, et al. (2007) Exosome-
mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic
exchange between cells. Nat Cell Biol 9:654–659.
30. Sokolova V, Ludwig AK, Hornung S, Rotan O, Horn PA, et al. (2011)
Characterisation of exosomes derived from human cells by nanoparticle tracking
analysis and scanning electron microscopy. Colloids Surf B Biointerfaces
87:146–50.
31. Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJ, et al. (2011)
Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking
Analysis. Nanomedicine 7:780–8.
32. Chen XM, Splinter PL, Tietz PS, Huang BQ, Billadeau DD, et al. (2004)
Phosphatidylinositol 3-kinase and frabin mediate Cryptosporidium parvum cellular
invasion via activation of Cdc42. J Biol Chem 279:31671–31678.
33. Kishore N, Sommers C, Mathialagan S, Guzova J, Yao M, et al. (2003) A
selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in
interleukin-1 beta-stimulated synovial fibroblasts. J Biol Chem 278:32861–
32871.
34. Verdon R, Polianski J, Grodet A, Garry L, Carbon C (1998) Cryptosporidium
parvum biliary tract infection in adult immunocompetent and immunosuppressed
mice. J Med Microbiol 47:71–77.
35. O’Hara SP, Bogert PST, Trussoni CE, Chen XM, LaRusso NF (2011) Tlr4
promotes Cryptosporidium parvum clearance in a mouse model of biliary
cryptosporidiosis. J Parasitol 97:813–821.
36. Savina A, Vidal M, Colombo MI (2002) The exosome pathway in K562 cells is
regulated by Rab11. J Cell Sci 115:2505–2515.
37. Suzuki K, Verma IM (2008) Phosphorylation of SNAP-23 by IkappaB kinase 2
regulates mast cell degranulation. Cell 134:485–495.
38. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, et al. (2004) A pancreatic
islet-specific microRNA regulates insulin secretion. Nature 432:226–230.
39. Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F, et
al. (2006) MicroRNA-9 controls the expression of Granuphilin/Slp4 and the
secretory response of insulin-producing cells. J Biol Chem 281:26932–26942.
40. Lovis P, Gattesco S, Regazzi R (2008) Regulation of the expression of
components of the exocytotic machinery of insulin-secreting cells by micro-
RNAs. Biol Chem 389:305–312.
41. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, et al. (2007)
Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature
449: 919–922.
42. Hu G, Zhou R, Liu J, Gong AY, Eischeid AN, et al. (2009) MicroRNA-98 and
let-7 confer cholangiocyte expression of cytokine-inducible Src homology 2-
containing protein in response to microbial challenge. J Immunol 183:1617–
1624.
43. Chen XM, LaRusso NF (2000) Mechanisms of attachment and internalization of
Cryptosporidium parvum to biliary and intestinal epithelial cells. Gastroenterology
118:368–379.
44. Bhat N, Joe A, PereiraPerrin M, Ward HD (2007) Cryptosporidium p30, a
galactose/N-acetylgalactosamine-specific lectin, mediates infection in vitro. J Biol
Chem 282:34877–34887.
45. Zaalouk TK, Bajaj-Elliott M, George JT, McDonald V (2004) Differential
regulation of beta-defensin gene expression during Cryptosporidium parvum
infection. Infect Immun 72:2772–2779.
46. Armogida SA, Yannaras NM, Melton AL, Srivastava MD (2004) Identification
and quantification of innate immune system mediators in human breast milk.
Allergy Asthma Proc 25:297–304.
47. Zegels G, Van Raemdonck GAA, Coen EP, Tjalma WAA, Van Ostade XWM
(2009) Comprehensive proteomic analysis of human cervical-vaginal fluid using
colposcopy samples. Proteome Sci 17:7–17.
48. Brandenburg K, Wagner F, Muller M, Heine H, Andra J, et al. (2003)
Physicochemical characterization and biological activity of a glycoglycerolipid
from Mycoplasma fermentans. Eur J Biochem 270:3271–3279.
Exosomal Anti-C. parvum Activity
PLOS Pathogens | www.plospathogens.org 13 April 2013 | Volume 9 | Issue 4 | e1003261
